Abigail Schwaede
Neuromuscular Medicine · Chicago, ILNPI 1861810822
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $45,207 of the $73,167 with a category attached, or 61.8%. 17 manufacturers reported payments, led by Sarepta Therapeutics, Inc. at 38.3% of the total. 2025 is the largest year on record at $39,343, more than ten times the $145 reported in 2019. Among neuromuscular medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $690.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$28K
- Johnson & Johnson$24K
- Biogen$9K
- Novartis$5K
- Janssen Scientific Affairs, LLC$5K
- Genentech, Inc.$1K
- plus $779 from 11 others
Across 10 payments — averaging $10,203 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- NS Pharma, Inc.$59K
- AstraZeneca$38K
- UCB SA$4K
What the payments were for
- Consulting fees$45,20762%
- Speaking & faculty fees$20,64528%
- Travel & lodging$3,8845%
- Food & beverage$3,2904%
- Education$1400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 26 | $28,030 |
| Johnson & Johnson(2 entities) | 27 | $23,727 |
| Biogen | 14 | $9,298 |
| Novartis | 7 | $5,193 |
| Janssen Scientific Affairs, LLC | 5 | $4,653 |
| Genentech, Inc. | 4 | $1,486 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 5 | $193 |
| Akcea Therapeutics, Inc. | 1 | $122 |
| Catalyst Pharmaceuticals, Inc. | 4 | $116 |
| Ultragenyx Pharmaceutical Inc. | 3 | $73 |
| NS Pharma, Inc. | 3 | $62 |
| ITF Therapeutics LLC | 2 | $61 |
| Argenx US, Inc. | 1 | $56 |
| Genentech USA, Inc. | 1 | $29 |
| UCB, Inc. | 1 | $25 |
| CSL Behring | 1 | $23 |
| PTC Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$73,167 in reported general payments places this provider in the 95th percentile of 21 neuromuscular medicine providers in Illinois.
Other neuromuscular medicine in Chicago
- Arjun SethChicago$72K
- Erik PioroChicago$45K
- Senda Ajroud DrissChicago$23K
- Robert KalbChicago$22K
- Daniela MenichellaChicago$11K
- Robert SufitChicago$4K
- Richard HarveyChicago$3K
- Kyle MardenChicago$1K
- Gyeongmo SohnChicago$1K
- Adenike AdewuyiChicago$495
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.